Treg and lupus.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19995748.
- Also identified by DOI 10.1136/ard.2009.117135.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autoimmune diseases such as systemic lupus erythemathodes (SLE) display quantitative and/or qualitative deficiencies of CD4+CD25+ regulatory T cells (Treg). This might contribute to the immune dysregulation and break-down of peripheral tolerance mechanisms. In addition novel subsets of Treg might arise under specific autoimmune conditions as an effort to counteract autoimmunity. Advances in our understanding of how to characterise and manipulate Treg in patients with autoimmune diseases are required in order to develop new therapeutic strategies.
Medical subject headings
- Lupus Erythematosus, Systemic
- T-Lymphocytes, Regulatory